Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
- Other assay [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-37806 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Phospho-p47phox (Ser345) Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- A suggested positive control for Western blot is HepG2 cells; suggested positive control for IHC is human brain tissue.
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µL
- Concentration
- 1 mg/mL
- Storage
- -20°C
Submitted references GILZ restrains neutrophil activation by inhibiting the MAPK pathway.
TRPM2 regulates TXNIP-mediated NLRP3 inflammasome activation via interaction with p47 phox under high glucose in human monocytic cells.
Ricci E, Ronchetti S, Gabrielli E, Pericolini E, Gentili M, Roselletti E, Vecchiarelli A, Riccardi C
Journal of leukocyte biology 2019 Jan;105(1):187-194
Journal of leukocyte biology 2019 Jan;105(1):187-194
TRPM2 regulates TXNIP-mediated NLRP3 inflammasome activation via interaction with p47 phox under high glucose in human monocytic cells.
Tseng HH, Vong CT, Kwan YW, Lee SM, Hoi MP
Scientific reports 2016 Oct 12;6:35016
Scientific reports 2016 Oct 12;6:35016
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of extracts from HepG2 cells treated with TNF using p47 phox (pSer345) polyclonal antibody (Product # PA5-37806) (left) or the same antibody preincubated with a blocking peptide (right).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of Phospho-p47phox (Ser345) in paraffin-embedded Human brain tissue using Phospho-p47phox (Ser345) Polyclonal Antibody (Product # PA5-37806) (left) or the same antibody preincubated with blocking peptide (right).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 4 TRPM2 knockdwon markedly reduced p47 phox phosphorylation, TXNIP expression and Trx activity under HG in U937 monocytes. ( A ) Representative immunoblots and graphs for protein expressions of p47 phox, p22phox, gp91pox, TXNIP or GAPDH in the presence of BAPTA-AM (2.5, 5, 10 muM), or EGTA (0.5, 1, 5 mM) under low glucose (LG; 5.5 mM glucose) or high glucose (HG; 30 mM glucose) (n = 4-5). ( B ) Representative immunoblots and graphs for protein expressions of p47 phox, TXNIP or GAPDH or beta-actin in the presence of GAPDH- or TRPM2-siRNA under HG (n = 4). ( C ) Quantitative PCR was performed on TXNIP mRNA in GAPDH- (GA si) or TRPM2-siRNA-treated cells under LG or HG, and it was normalized to LG + GAPDH-siRNA (n = 4). ( D ) TRX activity was determined by the insulin disulfide reduction assay, and was normalized to LG + GAPDH-siRNA. The cells were stimulated with HG for 24, 48, 72 h in the presence of GAPDH- or TRPM2-siRNA (n = 4). Data were shown as mean +- S.E.M. ( C,D ) *P < 0.05 and ***P < 0.001 vs. LG + GAPDH-siRNA; # P < 0.05 and ### P < 0.001 vs. HG + GADPH-siRNA.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 5 TRPM2 interacted with p47 phox during HG stimulation in U937 monocytes. ( A,B ) Immunofluorescence images showing the location of the ( A ) FM4-64 (1 uM; cell membrane marker) and subcellular p47 phox, or ( B ) subcellular p47 phox and TRPM2, in fixed cells by using confocal microscopy. The cells were pre-treated with 3,4-dihydro-5-[4-(1-piperidinyl)butoxy]-1(2H)-isoquinolinone (DPQ; 100 muM) under low glucose (LG; 5.5 mM glucose;) or high glucose (HG; 30 mM glucose). The percentage of co-localization of p47 phox with ( A ) FM4-64, or ( B ) TRPM2, was calculated as the average volume of the overlapping areas (n = 4-5). ( C,D ) Representative immunoblots showing the immunoprecipitation results for the interaction of TRPM2 with p47 phox or phosphorylated-Ser345 p47 phox under high glucose (10, 20, 30 mM glucose) for 48 h (n = 4). Data were shown as mean +- S.E.M. ( A,B ) **P < 0.01 vs. LG; ## P < 0.01 vs. HG.
